Company
NUGENEREX IMMUNO-ONCOLOGY, INC. (0001804585)
Standardized SEC financial data for NUGENEREX IMMUNO-ONCOLOGY, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001804585 · Pharmaceutical Preparations.
Return on equity
26.1%
Income statement
| USD | FY2019 | FY2020 |
|---|---|---|
| R&D expense | $354K | $397K |
| SG&A expense | $39K | $336K |
| Operating income | -$393K | -$734K |
| Interest expense | $715K | $855K |
| Pretax income | -$1.1M | -$1.5M |
| Net income | $1.1M | $1.6M |
Standardized from NUGENEREX IMMUNO-ONCOLOGY, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
| Total assets | — | $389 | $84 |
| Total current liabilities | — | $4.4M | $5.8M |
| Total liabilities | — | $4.4M |
Get 0001804585 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001804585/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001804585/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"